Celltrion
068270.KS
#754
Rank
A$40.85 B
Marketcap
$197.24
Share price
0.72%
Change (1 day)
4.65%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$3.44 Billion

According to Celltrion 's latest financial reports the company's total liabilities are A$3.44 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$1.88 B0.15%
2021-12-31A$1.88 B-1.26%
2020-12-31A$1.90 B56.42%
2019-12-31A$1.21 B5.57%
2018-12-31A$1.15 B8.74%
2017-12-31A$1.06 B12.09%
2016-12-31A$0.94 B-13.57%
2015-12-31A$1.09 B0.79%
2014-12-31A$1.08 B14.71%
2013-12-31A$0.94 B49.76%
2012-12-31A$0.63 B48.17%
2011-12-31A$0.42 B30.2%
2010-12-31A$0.32 B24.01%
2009-12-31A$0.26 B-17.07%
2008-12-31A$0.31 B640.85%
2007-12-31A$43.05 M